Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The role of large immune complexes in anti-drug antibody development: a case study of anti-SARS-CoV-2 antibody therapeutics and co-administered mRNA vaccine.
Journal: Frontiers in immunology
Published: December 16, 2025
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection.
Journal: Science translational medicine
Published: November 06, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial.
Journal: The Lancet. Infectious diseases
Published: March 08, 2024
Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection.
Journal: Open forum infectious diseases
Published: September 19, 2023
A Prospective Study of Key Correlates for Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2.
Journal: Open forum infectious diseases
Published: February 02, 2023
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
Journal: Nature communications
Published: January 11, 2023
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.
Journal: The Lancet. Infectious diseases
Published: April 04, 2022
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 19, 2022
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
Journal: The New England journal of medicine
Published: August 04, 2021
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
Journal: medRxiv : the preprint server for health sciences
Published: June 23, 2021
Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention.
Journal: medRxiv : the preprint server for health sciences
Published: June 23, 2021
Last Updated: 09/26/2026